Artwork

Contenu fourni par Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.
Player FM - Application Podcast
Mettez-vous hors ligne avec l'application Player FM !

Johan Lauritsen: There needs to be a simple apply button to participate in a clinical trial

43:01
 
Partager
 

Manage episode 382347603 series 3526489
Contenu fourni par Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Send us a text

We speak to Johan Lauritsen, CEO & Founder of Probe, about how clinical trials can be an alternative to treatment.

Johan himself tried to enrol in a clinical trial for his rare chronic disease. This was an uphill battle and he never succeeded - but the experience did kindle his desire to make clinical trials available for patients.

Enrolling in a trial for a patient is not easy - even though especially chronic patients are very much willing to participate. But it is not easy for the physician to recruit patients for a clinical trial either. The problem is on both ends of the spectrum.

There is no democratic access to clinical trials for patients. Even though a patient may be eligible, they may not enrol participants who are new to trials.
Johan discusses the moral imperative of having open access to the newest treatment options for any patient fitting the criteria - wherever the trial is running in the world.

Johan also takes us through his solution for bridging the patients who are willing to participate - and the clinical sites recruiting for a clinical trial.
With the use of a simple apply button. But also by using the latest technology to ensure transparency of the use of data and security.

Guest:

Johan Lauritsen

https://www.linkedin.com/in/johanlauritsen/

PROBE

https://www.linkedin.com/company/probe-dk/

Links:

https://clinicaltrials.gov/

https://lighthouse.ku.dk/

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

  continue reading

67 episodes

Artwork
iconPartager
 
Manage episode 382347603 series 3526489
Contenu fourni par Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal. Tout le contenu du podcast, y compris les épisodes, les graphiques et les descriptions de podcast, est téléchargé et fourni directement par Sam Parnell & Ivanna Rosendal, Sam Parnell, and Ivanna Rosendal ou son partenaire de plateforme de podcast. Si vous pensez que quelqu'un utilise votre œuvre protégée sans votre autorisation, vous pouvez suivre le processus décrit ici https://fr.player.fm/legal.

Send us a text

We speak to Johan Lauritsen, CEO & Founder of Probe, about how clinical trials can be an alternative to treatment.

Johan himself tried to enrol in a clinical trial for his rare chronic disease. This was an uphill battle and he never succeeded - but the experience did kindle his desire to make clinical trials available for patients.

Enrolling in a trial for a patient is not easy - even though especially chronic patients are very much willing to participate. But it is not easy for the physician to recruit patients for a clinical trial either. The problem is on both ends of the spectrum.

There is no democratic access to clinical trials for patients. Even though a patient may be eligible, they may not enrol participants who are new to trials.
Johan discusses the moral imperative of having open access to the newest treatment options for any patient fitting the criteria - wherever the trial is running in the world.

Johan also takes us through his solution for bridging the patients who are willing to participate - and the clinical sites recruiting for a clinical trial.
With the use of a simple apply button. But also by using the latest technology to ensure transparency of the use of data and security.

Guest:

Johan Lauritsen

https://www.linkedin.com/in/johanlauritsen/

PROBE

https://www.linkedin.com/company/probe-dk/

Links:

https://clinicaltrials.gov/

https://lighthouse.ku.dk/

________
Reach out to Sam Parnell and Ivanna Rosendal
Join the conversation on our LinkedIn page

  continue reading

67 episodes

Minden epizód

×
 
Loading …

Bienvenue sur Lecteur FM!

Lecteur FM recherche sur Internet des podcasts de haute qualité que vous pourrez apprécier dès maintenant. C'est la meilleure application de podcast et fonctionne sur Android, iPhone et le Web. Inscrivez-vous pour synchroniser les abonnements sur tous les appareils.

 

Guide de référence rapide